From October 14, 2021 to April 13, 2022, the company has repurchased 251,612 shares, representing 0.89% for KRW 1,997.79 million. With this, the company has completed the repurchase of 251,612 shares, representing 0.89% for KRW 1,997.79 million under the buyback announced on October 14, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,960 KRW | +1.16% | -11.68% | +22.97% |
1st Jan change | Capi. | |
---|---|---|
+22.97% | 138M | |
+37.73% | 727B | |
-7.90% | 354B | |
+15.65% | 328B | |
-0.42% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.79% | 164B | |
-2.10% | 164B |
- Stock Market
- Equities
- A006620 Stock
- News DongKoo Bio & Pharma Co., Ltd.
- Tranche Update on DongKoo Bio&Pharma Co., Ltd.'s Equity Buyback Plan announced on October 14, 2021.